AnalyzeDirect Whitwell JL, Xu J, Mandrekar JN, Gunter JL, Jack CR, Jr., Josephs KA. Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. Parkinsonism Relat Disord. March 2012;18(3):252-256.
Full Text – Open Access
Publication Date
March 2012
How Analyze was Used
“Area of the midbrain was measured manually by one rater (JLW) using Analyze software.”
Keywords
Adult
Aged
Atrophy/pathology
Brain/pathology
Clinical Trials as Topic
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Sample Size
Supranuclear Palsy, Progressive/pathology
Author Affiliation(s)
Department of Radiology, Mayo Clinic, Rochester, MN, US. (JLW, CRJ)
Department of Health Sciences Research (Biostatistics), Mayo Clinic, Rochester, MN, US. (JX, JNM)
Department of Information Technology, Mayo Clinic, Rochester, MN, US. (JLG)
Department of Neurology, Mayo Clinic, Rochester, MN, US. (KAD)
ID# 542
Tags: Adult, Aged, Atrophy/pathology, Brain/pathology, Clinical Trials as Topic, Female, Humans, Magnetic Resonance Imaging (MRI), Male, Middle Aged, Progressive Supranuclear Palsy/pathology, Sample Size